Back to top

Image: Bigstock

Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher

Read MoreHide Full Article

Abeona Therapeutics Inc. was a big mover last session, as the company saw its shares rise nearly 23% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 102.4% in the past one-month time frame.

The stock gained after an analyst from RBC Capital initiated coverage of the gene therapy company with an outperform rating.

The company has seen no estimate revisions over the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Abeona Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.  

A better-ranked stock in the Medical - Biomedical and Genetics industry is Alexion Pharmaceuticals, Inc. , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ABEO going up? Or down? Predict to see what others think: Up or Down

New Report: An Investor’s Guide to Cybersecurity

Cyberattacks have become more frequent and destructive than ever. In fact, they’re expected to cause $6 trillion per year in damage by 2020.

The cybersecurity industry is expanding quickly in response to these threats. In fact, a projected $170 billion per year will be spent to protect consumer and corporate assets. Zacks has just released Cybersecurity: An Investor’s Guide to Locking Down Profits which reveals 4 promising investment candidates.

Download the new report now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Abeona Therapeutics Inc. (ABEO) - free report >>

Published in